Gene: ERAP1
Official Full Name: endoplasmic reticulum aminopeptidase 1provided by HGNC
Gene Summary: The protein encoded by this gene is an aminopeptidase involved in trimming HLA class I-binding precursors so that they can be presented on MHC class I molecules. The encoded protein acts as a monomer or as a heterodimer with ERAP2. This protein may also be involved in blood pressure regulation by inactivation of angiotensin II. Three transcript variants encoding two different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00906 | ERAP1 Knockout cell line(293T) | Human | ERAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO17922 | ERAP1 Knockout cell line (HeLa) | Human | ERAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO17923 | ERAP1 Knockout cell line (HCT 116) | Human | ERAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO17924 | ERAP1 Knockout cell line (HEK293) | Human | ERAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO17925 | ERAP1 Knockout cell line (A549) | Human | ERAP1 | 1:3~1:4 | Negative | Online Inquiry |
ERAP1 Gene Knockout Cell Lines are genetically engineered cell lines in which the ERAP1 gene has been selectively disrupted, resulting in the loss of its expression and functional activity. ERAP1 (Endoplasmic Reticulum Aminopeptidase 1) plays a critical role in the processing of precursors to antigenic peptides, which are subsequently presented on major histocompatibility complex (MHC) class I molecules. By studying these knockout lines, researchers can gain deeper insights into the molecular mechanisms of antigen presentation, immune responses, and the pathogenesis of related diseases.
The key function of ERAP1 is its involvement in trimming peptides in the endoplasmic reticulum to optimal lengths for loading onto MHC class I molecules, thus influencing T cell recognition and activation. The knockout of ERAP1 allows researchers to investigate the resulting alterations in peptide presentation and immune response, thereby providing a valuable tool for studying autoimmune diseases, cancers, and infectious diseases where the immune system's ability to recognize and respond to tumors or pathogens is crucial.
The scientific importance of ERAP1 Gene Knockout Cell Lines extends to their applications in both fundamental research and clinical settings. These lines can be utilized in drug discovery, immunotherapy development, and the exploration of vaccine efficacy, presenting opportunities to innovate therapeutically in the treatment of diseases where immune modulation is a pivotal factor.
Compared to alternative models, these knockout cell lines offer specific advantages, including precise control over gene expression and easy manipulation to study downstream signaling pathways. Additionally, they eliminate confounding factors that could arise in wild-type lines, allowing for clearer experimental results.
This product is invaluable to researchers and clinicians keen on unraveling the complexities of human immunology and developing novel therapeutic strategies. By employing ERAP1 Gene Knockout Cell Lines, users can open new avenues in their investigations, driving forward the understanding of immune mechanisms and ultimately contributing to improved health outcomes.
With extensive experience in genetic engineering and a commitment to advancing biomedical research, our company stands at the forefront of providing high-quality biological products, including tailored knockout cell lines designed to meet the specific needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.